Tris Pharma Recalls
8 recalls on record · September 6, 2017 to July 31, 2019 · Drugs
Recalls by year
17
18
19
Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.
July 31, 2019DrugsFDA
Tris Pharma Inc. recalls Hydrocodone Polistirex and Chlorpheniramine Polistirex Extended-Release Suspension, (equivalent to 10 mg hydrocodone bit
Hazard: Superpotent Drug and Failed Stability Specifications: High out-of-specification results for the active ingredients, hydrocodone and chlorpheniramine, as well as high out-of-specification results for the preservatives.
February 20, 2019DrugsFDA
Tris Pharma Inc. recalls Infants' Ibuprofen, Concentrated Ibuprofen Oral Suspension, USP, (NSAID), 50 mg per 1.25 mL, Dye Free, Non-staining Berr
Hazard: Superpotent Drug: recalled lots may have higher concentration of ibuprofen than amount labeled.
February 20, 2019DrugsFDA
Tris Pharma Inc. recalls infants* IBUPROFEN, Concentrated Ibuprofen Oral Suspension, USP (NSAID), 50 mg per 1.25 mL, Dye-Free Berry Flavor, 1 FL
Hazard: Superpotent Drug: recalled lots may have higher concentration of ibuprofen than amount labeled.
February 20, 2019DrugsFDA
Tris Pharma Inc. recalls Infants' Ibuprofen, Concentrated Ibuprofen Oral Suspension, USP, (NSAID), 50 mg per 1.25 mL, Dye Free, Non-staining Berr
Hazard: Superpotent Drug: recalled lots may have higher concentration of ibuprofen than amount labeled.
December 26, 2018DrugsFDA
Tris Pharma Inc. recalls Infants' Ibuprofen, Concentrated Ibuprofen Oral Suspension, USP, (NSAID), 50 mg per 1.25 mL, Dye Free, Non-staining Berr
Hazard: Superpotent Drug: recalled lots may have higher concentration of ibuprofen.
December 26, 2018DrugsFDA
Tris Pharma Inc. recalls Infants' Ibuprofen, Concentrated Ibuprofen Oral Suspension, USP, (NSAID), 50 mg per 1.25 mL, Dye-Free Non-Staining Berry
Hazard: Superpotent Drug: recalled lots may have higher concentration of ibuprofen.
December 26, 2018DrugsFDA
Tris Pharma Inc. recalls infants* IBUPROFEN, Concentrated Ibuprofen Oral Suspension, USP (NSAID), 50 mg per 1.25 mL, Dye-Free Berry Flavor, 0.5 F
Hazard: Superpotent Drug: recalled lots may have higher concentration of ibuprofen.
September 6, 2017DrugsFDA
Tris Pharma Inc. recalls Morphine Sulfate Oral Solution, 100 mg/ 5 mL (20 mg/mL), packaged in a 1 oz. bottle containing 30 mL with an oral syring
Hazard: Defective container: Oral solution leaking from container.